Literature DB >> 10668712

Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging.

K Rockwood1, C Wentzel, V Hachinski, D B Hogan, C MacKnight, I McDowell.   

Abstract

OBJECTIVE: To assess the importance of vascular cognitive impairment and its three subgroups (cognitive impairment, no dementia; vascular dementia; and AD with a vascular component) to the prevalence and burden of cognitive impairment in elderly people.
BACKGROUND: Vascular lesions may produce a spectrum of cognitive changes. Omitting elderly patients whose cognitive impairment falls short of dementia (vascular cognitive impairment, no dementia) may give a falsely low indication of the prevalence and burden of disease. To test this proposition, we compared the rates of adverse outcomes for patients with no cognitive impairment, vascular cognitive impairment (and its subgroups), and probable AD.
METHODS: The Canadian Study of Health and Aging is a prospective cohort study of 10,253 randomly selected community-dwelling and institution-dwelling respondents aged 65 years or older. In the community, all participants (n = 9,008) were screened for cognitive impairment; those who screened positive and a sample of those who screened negative received a clinical assessment (n = 1,659). All patients living in institutions received a clinical assessment (n = 1,255). Participants were reassessed 5 years after the original survey.
RESULTS: Vascular cognitive impairment without dementia was the most prevalent form of vascular cognitive impairment among those aged 65 to 84 years. Rates of institutionalization and mortality for those with vascular cognitive impairment were significantly higher than those of people who had no cognitive impairment, and the mortality rate for patients with vascular cognitive impairment was similar to that of patients with AD.
CONCLUSIONS: Failure to consider vascular cognitive impairment without dementia underestimates the prevalence of impairment and the risk for adverse outcomes associated with vascular cognitive impairment.

Entities:  

Mesh:

Year:  2000        PMID: 10668712     DOI: 10.1212/wnl.54.2.447

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  71 in total

1.  Effects of chronic guanosine treatment on hippocampal damage and cognitive impairment of rats submitted to chronic cerebral hypoperfusion.

Authors:  Marcelo Ganzella; Enderson Dias Alves de Oliveira; Daniel Diniz Comassetto; Fernanda Cechetti; Victor Hermes Cereser; Júlia Dubois Moreira; Gisele Hansel; Roberto Farina Almeida; Denise Barbosa Ramos; Yanier Nuñes Figueredo; Debora Guerini Souza; Jean Pierre Oses; Paulo Valdeci Worm; Matilde Achaval; Carlos Alexandre Netto; Diogo Onofre Souza
Journal:  Neurol Sci       Date:  2011-12-14       Impact factor: 3.307

Review 2.  Vascular cognitive impairment, a cardiovascular complication.

Authors:  Adiukwu Frances; Ofori Sandra; Ugbomah Lucy
Journal:  World J Psychiatry       Date:  2016-06-22

Review 3.  Vascular cognitive impairment and Alzheimer's disease: role of cerebral hypoperfusion and oxidative stress.

Authors:  Hyun Ah Kim; Alyson A Miller; Grant R Drummond; Amanda G Thrift; Thiruma V Arumugam; Thanh G Phan; Velandai K Srikanth; Christopher G Sobey
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-08-08       Impact factor: 3.000

4.  Demographic and CT scan features related to cognitive impairment in the first year after stroke.

Authors:  S M C Rasquin; F R J Verhey; R J van Oostenbrugge; R Lousberg; J Lodder
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

5.  Mineralocorticoid receptor antagonism prevents obesity-induced cerebral artery remodeling and reduces white matter injury in rats.

Authors:  Paulo W Pires; Jonathon L McClain; Sebastian F Hayoz; Anne M Dorrance
Journal:  Microcirculation       Date:  2018-06-07       Impact factor: 2.628

Review 6.  Vascular cognitive impairment.

Authors:  Muhammad U Farooq; Philip B Gorelick
Journal:  Curr Atheroscler Rep       Date:  2013-06       Impact factor: 5.113

7.  Pathophysiology of vascular dementia.

Authors:  Francesco Iemolo; Giovanni Duro; Claudia Rizzo; Laura Castiglia; Vladimir Hachinski; Calogero Caruso
Journal:  Immun Ageing       Date:  2009-11-06       Impact factor: 6.400

8.  Promotion of the mind through exercise (PROMoTE): a proof-of-concept randomized controlled trial of aerobic exercise training in older adults with vascular cognitive impairment.

Authors:  Teresa Liu-Ambrose; Janice J Eng; Lara A Boyd; Claudia Jacova; Jennifer C Davis; Stirling Bryan; Philip Lee; Penny Brasher; Ging-Yuek R Hsiung
Journal:  BMC Neurol       Date:  2010-02-17       Impact factor: 2.474

9.  Poststroke Neuropsychiatric Illness: An Integrated Approach to Diagnosis and Management.

Authors:  James A. Bourgeois; Donald M. Hilty; Celia H. Chang; Mark A. Wineinger; Mark E. Servis
Journal:  Curr Treat Options Neurol       Date:  2004-09       Impact factor: 3.598

10.  Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia.

Authors:  C DeCarli; D Mungas; D Harvey; B Reed; M Weiner; H Chui; W Jagust
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.